Lupin Digital Health’s Lyfe Platform gets Class C Medical Device License from CDSCO
First chronic condition management platform to be recognized as a Class C 'Software as a Medical Device'
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
AstraZeneca’s Lynparza to dominate PARP inhibitors market with $4 bn in sales by 2027: GlobalData
Most of Lynparza’s sales come from ovarian and HER2-negative breast cancer treatment
New Drug Application of Zydus’ Desidustat tablets by China Medical System Holdings accepted in China
Desidustat, administered orally is a novel, oral Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor (HIF-PHI) for treating…
Top 20 global biopharma companies report 9.6 per cent market cap growth in Q1 2024: GlobalData
it went from $3.67 trillion as on 31 December 2023 to $4 trillion as on 31 March 2024
Zydus launches Mirabegron ER tablets in US
Mirabegron is indicated for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency and…
Dr. Reddy’s launches condition management programme, DailyBloom IBS
It is a digital integrated care plan to manage Irritable Bowel Syndrome
Biocon signs licensing and supply pact with Biomm S.A for Semaglutide commercialisation in Brazil
Semaglutide (gOzempic), which is used to improve glycemic control in adults with type-2 diabetes
ENTOD Pharma gets CDSCO approval for eye drops to treat presbyopia
Clinical trials have demonstrated PresVu's efficacy in enhancing close-up vision within minutes of application
MASH innovator drug partnerships surge over $2.5 bn in 2024YTD: GlobalData
MASH drugs secured over $5.7 billion in total partnership deal value from 2018 to 2024YTD, where 2024YTD is already the top year…
Amneal launches PEMRYDI RTU, ready-to-use version of pemetrexed, oncology injectable medicine
PEMRYDI RTU injectable is available in two vial sizes: 100mg/10mL and 500 mg/50mL
Gilead Sciences announces $4 mn ALL4LIVER grant for viral hepatitis elimination by 2030
Indian organisations Chennai Liver Foundation and FIND receive the grant
Industry growth weakens sharply in Mar’24
For the 12 months through Mar’24, IPM grew 7.6 per cent YoY and prices/volume/new launches increased by 4.0 per cent/0.7 per…
Glenmark recalls 6,528 bottles of BP drug in US
The affected lot has been produced in India and is being recalled by for failed dissolution specifications
Basilea’s Zevtera will play unique yet critical role in MRSAB: GlobalData
It is the first new therapy to gain FDA approval in over 15 years
Granules India’s Vizag facility completes US FDA inspection with zero 483 observations
This facility manufactures APIs and formulations of oncology and non-oncology products
SII partners with Univercells for affordable personalised oncology
Univercells and SII believe that they may be able to dramatically accelerate the progress of new medicines
Asahi Kasei Bioprocess and Axolabs partner to accelerate oligonucleotide therapeutics development
Oligonucleotide therapies offer a targeted approach to modulating gene expression, splicing, and protein production.
Dr Reddy’s launches drug-free migraine management device Nerivio in Europe
Nerivio uses Remote Electrical Neuromodulation (REN) mechanism for acute and/or prevention migraine (with or without aura)…
CRISPR-based innovations drive $21 bn in pharma licensing deals over five years: GlobalData
The pharma industry has experienced a notable uptick in licensing agreements for innovator drugs incorporating clustered regularly…
DKSH Performance Materials acquires Elite Organic in Malaysia
This deal expands DKSH to life science business in the Asia Pacific